Xiuling Lv
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
-
- Cancer, Hypoxia, and Metabolism 4
- MicroRNA in disease regulation 1
- Co-authors
- Qiaoyou Weng (11 shared papers)Minjiang Chen (9 shared papers)Shiji Fang (9 shared papers)Jiansong Ji (10 shared papers)Gaofeng Shu (6 shared papers)Zhongwei Zhao (7 shared papers)Wei Weng (5 shared papers)Jiansong Ji (4 shared papers)
In The Last Decade
Xiuling Lv
14 papers receiving 387 citations
Peers
Comparison fields: 5 of 62
- Hepatology 123
- Cancer Research 90
- Radiology, Nuclear Medicine and Imaging 121
- Pulmonary and Respiratory Medicine 117
- Biomaterials 38
Countries citing papers authored by Xiuling Lv
This map shows the geographic impact of Xiuling Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiuling Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiuling Lv more than expected).
Fields of papers citing papers by Xiuling Lv
This network shows the impact of papers produced by Xiuling Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiuling Lv. The network helps show where Xiuling Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiuling Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 97 | |
| 2 | 2020 | 50 | |
| 3 | 2022 | 45 | |
| 4 | 2019 | 42 | |
| 5 | 2019 | 22 | |
| 6 | 2020 | 22 | |
| 7 | 2020 | 22 | |
| 8 | 2021 | 18 | |
| 9 | 2020 | 18 | |
| 10 | 2021 | 15 | |
| 11 | 2021 | 14 | |
| 12 | 2021 | 11 | |
| 13 | 2020 | 10 | |
| 14 | 2020 | 1 |
About Xiuling Lv
Xiuling Lv is a scholar working on Hepatology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Biomedical Engineering, having authored 14 papers that have together received 387 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Nanoplatforms for cancer theranostics (4 papers), Cancer, Hypoxia, and Metabolism (4 papers), Radiomics and Machine Learning in Medical Imaging (3 papers), RNA modifications and cancer (2 papers), Ferroptosis and cancer prognosis (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Hepatology (123 citations), Cancer Research (90 citations), Radiology, Nuclear Medicine and Imaging (121 citations), Pulmonary and Respiratory Medicine (117 citations) and Biomaterials (38 citations). Xiuling Lv has collaborated with scholars based in China, Czechia and Japan. Frequent co-authors include Qiaoyou Weng, Minjiang Chen, Shiji Fang, Jiansong Ji, Gaofeng Shu, Zhongwei Zhao, Wei Weng, Jiansong Ji, Jingjing Song and Liyun Zheng. Their work appears in journals such as Cell Communication and Signaling, Biomaterials, Frontiers in Oncology, European Journal of Radiology and ACS Applied Bio Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.